Skip to content
Loading…
Once one of Britain’s most celebrated biotech listings, Oxford Nanopore Technologies Plc is on the comeback trail after its early promise gave way to years of share-price underperformance.
To respect copyright, we link to the source rather than republishing the full text. Read the complete article on Bloomberg.